COMPUTCHEM LLC

Biotech · Private

iTitrate and iKa: software tools for predicting protein pKa values and small-molecule protonation states using molecular dynamics simulations and AI

Grants
$1.5M
3 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · A Cloud-Based Web Application to Accelerate Targeted Covalent Drug Discovery$167,551
Federal grantDepartment of Health and Human Services · Phase II · Molecular Dynamics and Artificial Intelligence Based Tools to Innovate Covalent and Noncovalent Drug Design$702,792
Federal grantDepartment of Health and Human Services · Phase II · Molecular Dynamics and Artificial Intelligence Based Tools to Innovate Covalent and Noncovalent Drug Design$671,205
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2718Mendra——
2719GLYTR THERAPEUTICS, INC.——
2720SCINTILLATION NANOTECHNOLOGIES INC——
2721COMPUTCHEM LLC——
2722MIDWEST BIOPROCESSING CENTER LLC——
2723Accuronix Therapeutics Inc——
2724Alveus Pharma——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.